Ventricular tachycardia due to flumazenil administration

Area of Science:

• Cardiology
• Clinical Pharmacology
• Toxicology

Background:

• Flumazenil is a selective benzodiazepine antagonist used for treating benzodiazepine overdose and in diagnostic settings.
• Its safety profile is generally well-established, with few serious adverse events reported.

Observation:

• A patient with lorazepam intoxication developed ventricular tachycardia shortly after flumazenil administration.
• The ventricular tachycardia was successfully treated with amiodarone.

Findings:

• This case suggests a potential link between flumazenil administration and the onset of ventricular tachycardia in a patient with a history of ischemic heart disease.
• Ventricular tachycardia is a rare but serious potential side effect of flumazenil.

Implications:

• Clinicians should be aware of this rare adverse effect, especially in patients with underlying cardiac conditions.
• Further investigation may be warranted to understand the mechanism and identify risk factors for flumazenil-induced arrhythmias.